11:08 AM EDT, 05/23/2025 (MT Newswires) -- European equities traded in the US as American depositary receipts were lower late Friday morning, declining 0.65% to 1,440.58 on the S&P Europe Select ADR Index, which was up 0.5% for the week.

From continental Europe, the gainers were led by medical device maker EDAP TMS (EDAP) and biotech firm Evaxion ( EVAX ) , which rose 2.8% and 1.1%, respectively. They were followed by biopharmaceutical companies Cellectis ( CLLS ) and Grifols ( GRFS ) , which were up 1% and 0.9%, respectively.

The decliners from continental Europe were led by furniture maker Natuzzi (NTZ) and biopharmaceutical company Genfit ( GNFT ) , which fell 7.7% and 3.2% respectively. They were followed by accommodations booking company trivago (TRVG) and biotech firm BioNTech (BNTX), which were down 2.9% and 2.4%, respectively.

From the UK and Ireland, the gainers were led by biopharmaceutical company Akari Therapeutics ( AKTX ) and tobacco company British American Tobacco ( BTI ) , which advanced 3.1% and 1%, respectively. They were followed by mining company BHP Group ( BHP ) and biopharmaceutical company Verona Pharma ( VRNA ) , which increased 0.9% and 0.6%, respectively.

The decliners from the UK and Ireland were led by biopharmaceutical companies Biodexa Pharmaceuticals ( BDRX ) and NuCana ( NCNA ) , which dropped 17% and 5.9%, respectively. They were followed by software company Endava ( DAVA ) and biotech firm Trinity Biotech ( TRIB ) , which lost 2.9% and 2.8%, respectively.